Article Text

Download PDFPDF
Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions
  1. K M J Douglas1,
  2. E Ladoyanni2,
  3. G J Treharne3,
  4. E D Hale1,
  5. N Erb1,
  6. G D Kitas1
  1. 1Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands, UK
  2. 2Department of Dermatology, Dudley Group of Hospitals NHS Trust
  3. 3School of Psychology, University of Birmingham, Birmingham, UK
  1. Correspondence to:
    G D Kitas
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Esk House, Russells Hall Hospital, Dudley, West Midlands DY1 2HQ, UK; GD.Kitas{at}


Background: Cutaneous abnormalities are common in rheumatoid arthritis, but exact prevalence estimates are yet to be established. Some abnormalities may be independent and coincidental, whereas others may relate to rheumatoid arthritis or its treatment.

Objectives: To determine the exact nature and point prevalence of cutaneous abnormalities in patients with rheumatoid arthritis compared with those in patients with non-inflammatory rheumatic disease.

Methods: 349 consecutive outpatients for rheumatology (205 with rheumatoid arthritis and 144 with non-inflammatory rheumatic conditions) were examined for skin and nail signs by a dermatologist. Histories of rheumatology, dermatology, drugs and allergy were noted in detail.

Results: Skin abnormalities were reported by more patients with rheumatoid arthritis (61%) than non-inflammatory controls (47%). More patients with rheumatoid arthritis (39%) than controls (10%) attributed their skin abnormality to drugs. Cutaneous abnormalities observed by the dermatologist were also more common in patients with rheumatoid arthritis (76%) than in the group with non-inflammatory disease (60%). Specifically, bruising, athlete’s foot, scars, rheumatoid nodules and vasculitic lesions were more common in patients with rheumatoid arthritis than in controls. The presence of bruising was predicted only by current steroid use. The presence of any other specific cutaneous abnormalities was not predicted by any of the variables assessed. In the whole group, current steroid use and having rheumatoid arthritis were the only important predictors of having any cutaneous abnormality.

Conclusions: Self-reported and observed cutaneous abnormalities are more common in patients with rheumatoid arthritis than in controls with non-inflammatory disease. These include cutaneous abnormalities related to side effects of drugs or to rheumatoid arthritis itself and other abnormalities previously believed to be independent but which may be of clinical importance.

  • DMARD, disease-modifying antirheumatic drug
  • NSAID, non-steroidal anti-inflammatory drug
  • SLE, systemic lupus erythematosus
  • TNF, tumour necrosis factor

Statistics from


  • Published Online First 13 February 2006

  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.